Boeing Co is making progress toward getting its 737 MAX aircraft in the air again but the Federal Aviation Administration (FAA) will need at least several more weeks for review, FAA Administrator Steve Dickson said on Tuesday.
Wall Street opened higher on Tuesday after a batch of upbeat earnings reports eased concerns over domestic growth and the fallout from the U.S.-China trade war, while a surge in Biogen boosted the healthcare sector.
Microsoft is set to report earnings tomorrow, and analysts have high expectations. Yahoo Finance’s Alexis Christoforous and Brian Sozzi preview the quarter with Dan Morgan, VP and Senior Portfolio Manager at Synovus Trust. …read more […]
The market has been volatile in the last few months as the Federal Reserve continued its rate cuts and uncertainty looms over trade negotiations with China. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 10 percentage […] …read more […]
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates. In the first […] …read more […]
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock picking abilities to illustrate. The Standard and Poor’s 500 Index returned approximately 20% in 2019 (through September 30th). Conversely, hedge […] …read more […]
United Technologies expects Boeing to maintain production of its 737 MAX planes at the current rate for the rest of 2019, Chief Financial Officer Akhil Johri said on Tuesday, allaying fears of a complete halt in production.
Harley-Davidson Inc beat expectations for profit on Tuesday and stuck to its full-year shipment forecast, allaying fears of another major hit from European import tariffs and a further slump in sales in its main U.S. market.
WeWork’s board has accepted a takeover plan proposed by Softbank Group, handing control of the office-sharing startup to the Japanese firm, according to a source directly familiar with the matter.
Reuters reported on Monday that SoftBank had offered a package worth nearly $10 billion to WeWork and its shareholders under a plan that would keep the company afloat and lead to the exit of its Chairman Adam Neumann. The Wall Street Journal reported on Tuesday that under the deal agreed with the board, Neumann would be paid nearly $1.7 billion by SoftBank, funded by a new credit line and the sale of roughly $1 billion of his WeWork stock. …read more […]
(Bloomberg) — An auction next month of oilfields in Brazil may be the priciest ever held, raising at least $50 billion in licensing fees and compensation, according to people familiar with government estimates.Exxon Mobil Corp., Royal Dutch Shell Plc and other energy giants are set to vie for deep-sea deposits that could hold 15 billion barrels of oil, almost twice as much as Norway’s reserves. Winners at the Nov. 6 auction are expected to pay $25 billion in licensing fees, plus share a portion of their production with the government.In addition, bidders will need to negotiate payments to state-controlled Petroleo …read more […]
Mcdonalds reported a miss on profit and sales in its third quarter earnings, and investors are disappointed. Yahoo Finance’s Brian Sozzi, Alexis Christoforous, and Heidi Chung break down the numbers. …read more […]
The S&P 500 and Nasdaq were set to open higher on Tuesday after a batch of upbeat earnings reports eased concerns over domestic growth and the fallout from the U.S.-China trade war, but weak results from McDonald’s looked set to weigh on the Dow index.
Huawei Technologies Co Ltd will utilize its 5G technologies to develop radar for self-driving cars, its deputy chairman told a conference, as the Chinese manufacturer looks to play a bigger role in the auto industry.
Bristol-Myers Squibb Co said on Tuesday an interim analysis of a late-stage trial testing a combination of its immuno-oncology drugs Opdivo and Yervoy met the main goal of extending life of previously untreated lung cancer patients. The company said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to chemotherapy alone in patients with advanced non-small cell lung cancer, the most common form of the disease. Data presented at a medical meeting last month showed that about 40% of patients with advanced lung cancer on the Opdivo-Yervoy combination were alive after two years, …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
